/Investor DB

FoundersX Ventures — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

MARKABLEmarkable.aiJun 2024

Markable.ai is an all-in-one platform for affiliate creators to monetize content through Amazon, Target, and Walmart deeplinks, featuring automated tools for link management, content boosting, and performance optimization.

AI & Machine LearningCreator EconomyMarketing TechMadison, US

Joy Tang(Executive Officer, Director)inFiona Wang(Executive Officer, Director)

BoardSheng Fu(Director)

Board seatHelen Liang· per SEC Form D

Co-investorsArbor VenturesFounderPartnersNOEMIS VenturesPartech VenturesPlug and Play VenturesPlum Alley Investments+1 more

Charge Roboticschargerobotics.comJul 2024

Charge Robotics automates labor-intensive tasks in solar construction to address deployment bottlenecks as demand for solar energy grows.

Advanced ManufacturingCleantechClimate TechConstruction TechRoboticsSan Francisco, US

Banks Hunter(Founder)inMax Justicz(Founder)inPhaedra Randolph(Head of Strategy and Operations)inHardeep Dhillon(Head of Talent Acquisition)Alec Page(Head of Operations \u0026 Strategy)Shreya Nathan(Chief of Staff)

Co-investorsATEL VenturesCollaborative FundGaingelsOutset CapitalSoma CapitalSun Road Syndicate+4 more

Glyphic Biotechnologiesglyphic.bioin𝕏Feb 2024

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)

BoardCraig Asher(Director)inJimmy Yun(Director)in

Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcGaingelsHarpoon VenturesIn-Q-Tel+10 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Cognito Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.